Report Categories
View AllRecent Articles
View All
China Investors Rush to Exit Overseas Markets Amid Crackdown on Illicit Trading
Adobe Faces Headwinds as AI Disruption Concerns Loom Over Creative Software Giant
From Boxcars to a BillionDollar Network The Rise of a Logistics Powerhouse
TikTok and YouTube Face Scrutiny Over Child Safety Standards by UK Regulator Ofcom
Political Risk and Market Complacency The Trump Corruption Factor
GOOGL Q1 2026 Earnings EPS Misses Amid Accelerated AI Investments
BATL Q2 2023 Earnings NarrowerThanExpected Loss Fails to Lift Shares
RILYN Q1 2024 Earnings Negative EPS and Bond Price Movement Amid Operational Challenges
STC Q1 2026 Earnings EPS Surges 485 Above Estimates Title Insurance Momentum Drives Strong Beat
SL Green Realty Corp Q1 2026 Earnings Significant EPS Miss Amidst Market Headwinds
XBP Global Holdings XBP Gains 3 Testing Key Resistance at 281
Lipocine Inc LPCN Edges Higher Amid Modest Uptick Technical Resistance in Sight
Forum Energy Technologies FET Slips 06 as Stock Consolidates Between Key Support and Resistance Levels
Rocket Lab RKLB Gains 548 as Shares Approach Key Resistance Level
Meta Cloud Expansion Possible If Data Center Capacity Exceeds Demand Zuckerberg Says
Government Plans Major Overhaul of Tax Administration to Ensure Smooth GST Rollout
SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Technology
PL Capital Highlights Three Adani Group Stocks for LongTerm Growth Potential
External Links
RBI Rate Cut May Signal Policy Framework Shift Nomura Suggests
POWI Q1 2026 Earnings EPS Surpasses Expectations Amidst Cautious Market Outlook
PSBD Q1 2026 Earnings Steep EPS Miss Sends Stock Flat Amid NonCash Adjustments
Outset Medical Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction
FCNCO Q1 2026 Earnings Preferred Dividend Coverage Strengthens with EPS Surprise
Jefferson Capital Inc JCAP Q1 2026 Earnings EPS Beats Estimates but Stock Slides on Mixed Signals
Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations
IVR Q1 2026 Earnings EPS Falls Short of Estimates Amid Continued Mortgage Market Challenges
Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns
TIMB Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement